211 related articles for article (PubMed ID: 10733489)
1. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
[TBL] [Abstract][Full Text] [Related]
2. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
[TBL] [Abstract][Full Text] [Related]
3. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
[TBL] [Abstract][Full Text] [Related]
4. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Mesa RA; Elliott MA; Tefferi A
Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
[TBL] [Abstract][Full Text] [Related]
5. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.
Akpek G; McAneny D; Weintraub L
J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
[TBL] [Abstract][Full Text] [Related]
7. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
Brenner B; Nagler A; Tatarsky I; Hashmonai M
Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
[TBL] [Abstract][Full Text] [Related]
8. [Splenectomy in 5 patients with idiopathic myelofibrosis].
Nozato A; Mizorogi F; Fukumi S; Watanabe H; Kobayashi M
Rinsho Ketsueki; 2001 Aug; 42(8):627-32. PubMed ID: 11579502
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for symptomatic hepatomegaly in myelofibrosis with myeloid metaplasia.
Tefferi A; Jiménez T; Gray LA; Mesa RA; Chen MG
Eur J Haematol; 2001 Jan; 66(1):37-42. PubMed ID: 11168506
[TBL] [Abstract][Full Text] [Related]
10. 2-Chlorodeoxyadenosine treatment after splenectomy in patients who have myelofibrosis with myeloid metaplasia.
Tefferi A; Silverstein MN; Li CY
Br J Haematol; 1997 Nov; 99(2):352-7. PubMed ID: 9375753
[TBL] [Abstract][Full Text] [Related]
11. Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.
Faoro LN; Tefferi A; Mesa RA
Eur J Haematol; 2005 Feb; 74(2):117-20. PubMed ID: 15654901
[TBL] [Abstract][Full Text] [Related]
12. The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia.
Benbassat J; Gilon D; Penchas S
Am J Hematol; 1990 Feb; 33(2):128-35. PubMed ID: 1689100
[TBL] [Abstract][Full Text] [Related]
13. Surgical and radiotherapeutic approaches for myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Semin Oncol; 2005 Aug; 32(4):403-13. PubMed ID: 16202686
[TBL] [Abstract][Full Text] [Related]
14. Myelofibrosis with myeloid metaplasia in adult individuals 30 years old or younger: presenting features, evolution and survival.
Cervantes F; Barosi G; Hernández-Boluda JC; Marchetti M; Montserrat E
Eur J Haematol; 2001 May; 66(5):324-7. PubMed ID: 11422412
[TBL] [Abstract][Full Text] [Related]
15. Splenectomy in myeloid metaplasia.
Cabot EB; Brennan MF; Rosenthal DS; Wilson RE
Ann Surg; 1978 Jan; 187(1):24-30. PubMed ID: 74243
[TBL] [Abstract][Full Text] [Related]
16. Splenectomy in advanced chronic lymphocytic leukemia: a single institution experience with 50 patients.
Neal TF; Tefferi A; Witzig TE; Su J; Phyliky RL; Nagorney DM
Am J Med; 1992 Oct; 93(4):435-40. PubMed ID: 1415307
[TBL] [Abstract][Full Text] [Related]
17. Myeloproliferative disorders.
Schwartz SI
Ann Surg; 1975 Oct; 182(4):464-71. PubMed ID: 1058648
[TBL] [Abstract][Full Text] [Related]
18. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.
Barosi G; Ambrosetti A; Centra A; Falcone A; Finelli C; Foa P; Grossi A; Guarnone R; Rupoli S; Luciano L; Petti MC; Pogliani E; Russo D; Ruggeri M; Quaglini S
Blood; 1998 May; 91(10):3630-6. PubMed ID: 9572998
[TBL] [Abstract][Full Text] [Related]
19. Thrombosis of the portal vein following splenectomy for myeloid metaplasia.
Broe PJ; Conley CL; Cameron JL
Surg Gynecol Obstet; 1981 Apr; 152(4):488-92. PubMed ID: 7209779
[TBL] [Abstract][Full Text] [Related]
20. [Portal hypertension after splenectomy for myeloid splenomegaly].
Perreau P; Joubaud F; Gardais J; Simard C
Sem Hop; 1972 Jan; 48(5):355-9. PubMed ID: 4339308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
